Segmentectomy for Solid-dominant Lung Cancer

Condition(s) studied

Investigational drug(s) / intervention(s)

Segmentectomy: The lungs are divided into multiple lobes. A segmentectomy involves the removal of part of one of the lobes of the lung to entirely remove a cancerous tumor. segmentectomy can preserve more normal functional lung tissues.

Study summary

This is a clinical trial from Eastern Cooperative Thoracic Oncology Project (ECTOP), numbered as ECTOP-1025. The goal of this clinical trial is to confirm the theraputic effect of segmentectomy for solid-dominant invasive lung cancer with size of 2-3cm. The main questions it aims to answer are:

* The 5-year disease-free survival of patients having solid-dominant invasive lung cancer with size of 2-3cm;
* The post-operative lung function tests after receiving segmentectomy. Participants will receive segmentectomy as the surgical procedure.

Eligibility

Primary outcome measure(s)

• 5-year disease-free survival — 5 years
  The event is defined as the tumor recurrence or the death due to any causes.

Trial sites (1)

More Fudan University trials in China

Other trials for the same condition